Bradley Foster & Sargent’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$133M Buy
264,936
+8,376
+3% +$4.02M 1.88% 9
2026
Q1
$126M Sell
256,560
-2,415
-0.9% -$1.31M 1.96% 9
2025
Q4
$150M Buy
258,975
+15,006
+6% +$8.49M 2.21% 8
2025
Q3
$118M Buy
243,969
+1,449
+0.6% +$674K 1.74% 11
2025
Q2
$98.3M Sell
242,520
-870
-0.4% -$364K 1.54% 15
2025
Q1
$121M Buy
243,390
+39,248
+19% +$21.3M 2.07% 10
2024
Q4
$106M Buy
204,142
+1,642
+0.8% +$903K 1.79% 10
2024
Q3
$125M Buy
202,500
+2,645
+1% +$1.57M 2.09% 9
2024
Q2
$111M Sell
199,855
-192
-0.1% -$110K 1.99% 9
2024
Q1
$116M Sell
200,047
-801
-0.4% -$449K 2.1% 8
2023
Q4
$107M Buy
200,848
+17,788
+10% +$8.61M 2.07% 7
2023
Q3
$95.5M Hold
183,060
2.01% 7
2023
Q2
$95.5M Buy
183,060
+5,825
+3% +$3.14M 2.01% 7
2023
Q1
$102M Sell
177,235
-340
-0.2% -$192K 2.44% 6
2022
Q4
$97.8M Sell
177,575
-1,839
-1% -$974K 2.45% 5
2022
Q3
$91M Sell
179,414
-819
-0.5% -$458K 2.52% 6
2022
Q2
$97.9M Sell
180,233
-12,281
-6% -$6.76M 2.52% 6
2022
Q1
$114M Sell
192,514
-1,352
-0.7% -$777K 2.43% 6
2021
Q4
$129M Buy
193,866
+134
+0.1% +$83.7K 2.68% 6
2021
Q3
$111M Buy
193,732
+291
+0.2% +$160K 2.6% 6
2021
Q2
$97.6M Sell
193,441
-556
-0.3% -$262K 2.28% 7
2021
Q1
$88.5M Buy
193,997
+290
+0.1% +$138K 2.24% 7
2020
Q4
$90.2M Sell
193,707
-23,088
-11% -$10.8M 2.38% 7
2020
Q3
$95.7M Buy
+216,795
New +$89.6M 2.8% 4
2020
Q1
$63M Sell
222,263
-7,294
-3% -$2.3M 2.52% 6
2019
Q4
$74.6M Sell
229,557
-1,760
-0.8% -$534K 2.3% 5
2019
Q3
$67.4M Sell
231,317
-3,248
-1% -$930K 2.25% 6
2019
Q2
$68.9M Sell
234,565
-546
-0.2% -$150K 2.28% 5
2019
Q1
$64.4M Sell
235,111
-2,983
-1% -$742K 2.25% 7
2018
Q4
$53.3M Sell
238,094
-5,065
-2% -$1.19M 2.15% 7
2018
Q3
$59.4M Buy
243,159
+43,039
+22% +$9.9M 2.01% 7
2018
Q2
$41.5M Buy
200,120
+3,639
+2% +$772K 1.48% 14
2018
Q1
$40.6M Sell
196,481
-5,986
-3% -$1.26M 1.54% 13
2017
Q4
$38.4M Sell
202,467
-895
-0.4% -$171K 1.39% 17
2017
Q3
$38.5M Sell
203,362
-4,294
-2% -$778K 1.47% 16
2017
Q2
$36.2M Buy
207,656
+241
+0.1% +$40.5K 1.45% 17
2017
Q1
$31.9M Sell
207,415
-4,407
-2% -$674K 1.29% 22
2016
Q4
$29.9M Buy
211,822
+426
+0.2% +$62.8K 1.27% 19
2016
Q3
$33.6M Sell
211,396
-5,395
-2% -$831K 1.47% 17
2016
Q2
$32M Sell
216,791
-2,153
-1% -$318K 1.44% 18
2016
Q1
$31M Sell
218,944
-67,831
-24% -$9.09M 1.44% 19
2015
Q4
$40.7M Sell
286,775
-4,910
-2% -$655K 1.86% 13
2015
Q3
$35.7M Buy
291,685
+1,311
+0.5% +$171K 1.76% 11
2015
Q2
$37.7M Buy
290,374
+4,862
+2% +$634K 1.72% 11
2015
Q1
$38.4M Buy
285,512
+41,829
+17% +$5.39M 1.75% 11
2014
Q4
$30.5M Buy
243,683
+118,081
+94% +$14.4M 1.44% 17
2014
Q3
$15.3M Buy
125,602
+9,171
+8% +$1.12M 0.73% 45
2014
Q2
$13.7M Buy
116,431
+47,005
+68% +$5.53M 0.67% 52
2014
Q1
$8.35M Buy
69,426
+2,927
+4% +$348K 0.43% 73
2013
Q4
$7.41M Sell
66,499
-1,560
-2% -$155K 0.39% 75
2013
Q3
$6.27M Sell
68,059
-17,858
-21% -$1.61M 0.37% 81
2013
Q2
$7.27M Buy
+85,917
New +$7.15M 0.45% 71

Other funds holding TMO

Bradley Foster & Sargent's TMO Position: Q2 2026 in Review

Bradley Foster & Sargent increased its Thermo Fisher Scientific (TMO) stake by 3.3% in Q2 2026, buying an estimated $4.02M and bringing the position to 264,936 shares worth $133M. The position accounts for 1.88% of the portfolio, ranked #9.

Bradley Foster & Sargent first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $150M in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bradley Foster & Sargent held 264,936 shares of Thermo Fisher Scientific worth $133M as of Q2 2026.
  • Bradley Foster & Sargent bought 8,376 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.02M.
  • Thermo Fisher Scientific made up 1.88% of Bradley Foster & Sargent's portfolio in Q2 2026, its #9 holding.
  • Bradley Foster & Sargent first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Bradley Foster & Sargent's Thermo Fisher Scientific position peaked at $150M in Q4 2025.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.